tiprankstipranks
Genmab A/S (MX:GMABN)
:GMABN
Mexico Market
GMABN
Genmab A/S
RESEARCH TOOLSreports

Genmab A/S (GMABN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

GMABN Analyst Ratings

Strong Buy
6Ratings
Strong Buy
5 Buy
1 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Genmab
A/S
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GMABN Stock 12 Month Forecast

Average Price Target

$6,440.32
▲(28.79% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Genmab A/S in the last 3 months. The average price target is $6,440.32 with a high forecast of $7,461.89 and a low forecast of $5,596.42. The average price target represents a 28.79% change from the last price of $5,000.66.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4026":"$4,026","4885":"$4,885","5744":"$5,744","6603":"$6,603","7462":"$7,462"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7461.891051999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$7K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6440.322634166665,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5596.418288999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.60K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4026,4885,5744,6603,7462],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5000.66,5189.9854655384615,5379.310931076923,5568.636396615384,5757.961862153846,5947.287327692307,6136.612793230769,6325.938258769231,6515.2637243076915,6704.589189846153,6893.914655384615,7083.240120923076,7272.565586461538,{"y":7461.891051999999,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5000.66,5111.403279551282,5222.1465591025635,5332.889838653846,5443.633118205127,5554.3763977564095,5665.119677307692,5775.862956858973,5886.606236410255,5997.349515961538,6108.092795512819,6218.836075064101,6329.579354615383,{"y":6440.322634166665,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5000.66,5046.487560692308,5092.315121384615,5138.142682076923,5183.97024276923,5229.797803461538,5275.625364153846,5321.452924846153,5367.280485538461,5413.108046230769,5458.935606923076,5504.763167615384,5550.590728307691,{"y":5596.418288999999,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4356.51,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4531.65,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5183.06,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5279.48,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5778.99,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5634.9,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5634.9,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5015.01,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4572.94,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4572.94,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4629.15,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4027.79,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5000.66,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$7,462Average Price Target$6,440Lowest Price Target$5,596
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on MX:GMABN
Rajan Sharma
Goldman Sachs
Goldman Sachs
$6,129.41→$6,262.66
Buy
25.24%
Upside
Reiterated
07/21/26
Genmab A/S (0MGB) Receives a Buy from Goldman Sachs
Jefferies Analyst forecast on MX:GMABN
Benjamin Jackson CFA
Jefferies
Jefferies
$7,461.89
Buy
49.22%
Upside
Reiterated
07/08/26
Jefferies Keeps Their Buy Rating on Genmab A/S (0MGB)
Barclays Analyst forecast on MX:GMABN
James Gordon CFA
Barclays
Barclays
$6,662.4
Buy
33.23%
Upside
Reiterated
07/02/26
Genmab A/S (0MGB) Gets a Buy from Barclays
Bank of America Securities Analyst forecast on MX:GMABN
Charlie Haywood
Bank of America Securities
Bank of America Securities
$6,662.4
Buy
33.23%
Upside
Reiterated
06/30/26
Genmab: Buy Rating Reiterated on Strong Epkinly Phase III Data and Late-Stage Pipeline; Price Target Unchanged at DKK 2,500
Deutsche Bank Analyst forecast on MX:GMABN
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
$6,395.91→$5,996.16
Buy
19.91%
Upside
Reiterated
05/11/26
Genmab price target lowered to DKK 2,250 from DKK 2,400 at Deutsche BankGenmab price target lowered to DKK 2,250 from DKK 2,400 at Deutsche Bank
Kepler Capital Analyst forecast on MX:GMABN
Jon Berggren
Kepler Capital
Kepler Capital
$5,596.42
Hold
11.91%
Upside
Reiterated
05/07/26
Genmab A/S (0MGB) Gets a Hold from Kepler Capital
Exane BNP Paribas Analyst forecast on MX:GMABN
Victor Floc'h
Exane BNP Paribas
Exane BNP Paribas
$6,395.91
Buy
27.90%
Upside
Upgraded
04/22/26
Genmab upgraded to Outperform from Neutral at BNP ParibasGenmab upgraded to Outperform from Neutral at BNP Paribas
UBS Analyst forecast on MX:GMABN
Xian Deng
UBS
UBS
$7,328.64→$6,928.9
Buy
38.56%
Upside
Assigned
03/26/26
UBS Remains a Buy on Genmab A/S (0MGB)
Bernstein Analyst forecast on MX:GMABN
Justin Smith
Bernstein
Bernstein
$2,704.94→$3,730.95
Sell
-25.39%
Downside
Reiterated
02/23/26
Genmab: Overvalued Amid Earnings Pressure, Dilutive Merus Deal, and Rising Patent‑Cliff Risks
J.P. Morgan Analyst forecast on MX:GMABN
Zain Ebrahim
J.P. Morgan
J.P. Morgan
$4,397.19→$5,463.17
Hold
9.25%
Upside
Reiterated
12/08/25
Genmab price target raised to DKK 2,050 from DKK 1,650 at JPMorganGenmab price target raised to DKK 2,050 from DKK 1,650 at JPMorgan
Guggenheim Analyst forecast on MX:GMABN
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
―
Hold
―
Reiterated
08/07/25
Guggenheim Keeps Their Hold Rating on Genmab A/S (0MGB)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs Analyst forecast on MX:GMABN
Rajan Sharma
Goldman Sachs
Goldman Sachs
$6,129.41→$6,262.66
Buy
25.24%
Upside
Reiterated
07/21/26
Genmab A/S (0MGB) Receives a Buy from Goldman Sachs
Jefferies Analyst forecast on MX:GMABN
Benjamin Jackson CFA
Jefferies
Jefferies
$7,461.89
Buy
49.22%
Upside
Reiterated
07/08/26
Jefferies Keeps Their Buy Rating on Genmab A/S (0MGB)
Barclays Analyst forecast on MX:GMABN
James Gordon CFA
Barclays
Barclays
$6,662.4
Buy
33.23%
Upside
Reiterated
07/02/26
Genmab A/S (0MGB) Gets a Buy from Barclays
Bank of America Securities Analyst forecast on MX:GMABN
Charlie Haywood
Bank of America Securities
Bank of America Securities
$6,662.4
Buy
33.23%
Upside
Reiterated
06/30/26
Genmab: Buy Rating Reiterated on Strong Epkinly Phase III Data and Late-Stage Pipeline; Price Target Unchanged at DKK 2,500
Deutsche Bank Analyst forecast on MX:GMABN
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
$6,395.91→$5,996.16
Buy
19.91%
Upside
Reiterated
05/11/26
Genmab price target lowered to DKK 2,250 from DKK 2,400 at Deutsche BankGenmab price target lowered to DKK 2,250 from DKK 2,400 at Deutsche Bank
Kepler Capital Analyst forecast on MX:GMABN
Jon Berggren
Kepler Capital
Kepler Capital
$5,596.42
Hold
11.91%
Upside
Reiterated
05/07/26
Genmab A/S (0MGB) Gets a Hold from Kepler Capital
Exane BNP Paribas Analyst forecast on MX:GMABN
Victor Floc'h
Exane BNP Paribas
Exane BNP Paribas
$6,395.91
Buy
27.90%
Upside
Upgraded
04/22/26
Genmab upgraded to Outperform from Neutral at BNP ParibasGenmab upgraded to Outperform from Neutral at BNP Paribas
UBS Analyst forecast on MX:GMABN
Xian Deng
UBS
UBS
$7,328.64→$6,928.9
Buy
38.56%
Upside
Assigned
03/26/26
UBS Remains a Buy on Genmab A/S (0MGB)
Bernstein Analyst forecast on MX:GMABN
Justin Smith
Bernstein
Bernstein
$2,704.94→$3,730.95
Sell
-25.39%
Downside
Reiterated
02/23/26
Genmab: Overvalued Amid Earnings Pressure, Dilutive Merus Deal, and Rising Patent‑Cliff Risks
J.P. Morgan Analyst forecast on MX:GMABN
Zain Ebrahim
J.P. Morgan
J.P. Morgan
$4,397.19→$5,463.17
Hold
9.25%
Upside
Reiterated
12/08/25
Genmab price target raised to DKK 2,050 from DKK 1,650 at JPMorganGenmab price target raised to DKK 2,050 from DKK 1,650 at JPMorgan
Guggenheim Analyst forecast on MX:GMABN
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
―
Hold
―
Reiterated
08/07/25
Guggenheim Keeps Their Hold Rating on Genmab A/S (0MGB)
Stocks with the Highest Top Analyst Consensus in the General Sector
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
CBRSCerebras Systems, Inc. Class A
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Genmab A/S

3 Months
Emmanuel PapadakisDeutsche Bank
Success Rate
11/21 ratings generated profit
52%
Average Return
+4.46%
Copying Emmanuel Papadakis's trades and holding each position for 3 Months would result in 52.38% of your transactions generating a profit, with an average return of +4.46% per trade.
1 Year
Emmanuel PapadakisDeutsche Bank
Success Rate
13/21 ratings generated profit
62%
Average Return
+8.55%
Copying Emmanuel Papadakis's trades and holding each position for 1 Year would result in 61.90% of your transactions generating a profit, with an average return of +8.55% per trade.
2 Years
Emmanuel PapadakisDeutsche Bank
Success Rate
15/21 ratings generated profit
71%
Average Return
+13.83%
Copying Emmanuel Papadakis's trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +13.83% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GMABN Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
1
1
0
0
0
Buy
6
8
8
9
4
Hold
1
1
1
1
0
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
10
9
10
4
In the current month, GMABN has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GMABN average Analyst price target in the past 3 months is 6,440.32.
Each month's total comprises the sum of three months' worth of ratings.

GMABN Financial Forecast

GMABN Earnings Forecast

Next quarter’s earnings estimate for GMABN is $61.41 with a range of $50.28 to $72.11. The previous quarter’s EPS was $14.32. GMABN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 51.30% of the time in the same period. In the last calendar year GMABN has Performed in-line its overall industry.
Next quarter’s earnings estimate for GMABN is $61.41 with a range of $50.28 to $72.11. The previous quarter’s EPS was $14.32. GMABN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 51.30% of the time in the same period. In the last calendar year GMABN has Performed in-line its overall industry.

GMABN Sales Forecast

Next quarter’s sales forecast for GMABN is $19.22B with a range of $18.06B to $20.18B. The previous quarter’s sales results were $15.23B. GMABN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.11% of the time in the same period. In the last calendar year GMABN has Performed in-line its overall industry.
Next quarter’s sales forecast for GMABN is $19.22B with a range of $18.06B to $20.18B. The previous quarter’s sales results were $15.23B. GMABN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.11% of the time in the same period. In the last calendar year GMABN has Performed in-line its overall industry.

GMABN Stock Forecast FAQ

What is MX:GMABN’s average 12-month price target, according to analysts?
Based on analyst ratings, Genmab A/S’s 12-month average price target is 6,440.32.
    What is MX:GMABN’s upside potential, based on the analysts’ average price target?
    Genmab A/S has 28.79% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Genmab A/S a Buy, Sell or Hold?
          Genmab A/S has a consensus rating of Strong Buy, which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Genmab A/S’s share price target?
            The average share price target for Genmab A/S is 6,440.32. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $7,461.89 ,and the lowest forecast is $5,596.42. The average share price target represents 28.79% Increase from the current price of $5,000.66.
              What do analysts say about Genmab A/S?
              Genmab A/S’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of Genmab A/S?
                To buy shares of MX:GMABN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.